Search for: "Appeal of Watson Industries" Results 41 - 60 of 139
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2016, 7:37 am by Steven Koprince
[Stars and Stripes] IBM’s Watson, the famous supercomputer that has bested Jeopardy! [read post]
13 Jul 2011, 3:04 am by Marie Louise
(America-Israel Patent Law) US: Will the dog days of summer offer a reprieve to FDA and the regulated industry (and your bleary-eyed bloggers)? [read post]
11 Aug 2011, 2:05 pm by Phil
We intend to appeal today's verdict and believe Nuance has a strong position based on both the facts and the law. [read post]
17 Jun 2013, 3:00 am by Gary P. Rodrigues
My answers were based on my personal experience in the legal publishing industry. [read post]
19 Oct 2010, 10:42 pm by Marie Louise
Honeywell (Patents Post-Grant) (IPBiz) (Patently-O) US: ‘At home’ testing for BRCA gene mutations (Patent Docs) US: New draft guidance for industry: INDs – determining whether human research studies can be conducted without an IND (FDA Law Blog) US: Patent extensions: some academic perspectives? [read post]
20 Jun 2016, 4:16 pm by Kayla Page
Court of Appeals for the District of Columbia Circuit upheld the Federal Communications Commission’s “net neutrality” rules in a really, really long opinion. [read post]
11 Oct 2010, 12:59 pm by FDABlog HPM
Since our last post, many more complaints have been filed alleging false marking by various parties in the FDA-regulated industry, including Ranbaxy, Roche Diagnostics Corporation, Walgreens, Bristol-Myers Squibb, Eisai, Takeda, Watson, and many, many  others. [read post]
6 Jul 2011, 2:21 am by Marie Louise
(Patent Baristas) US: FDA’s Chief Counsel, Ralph Tyler, set to leave FDA (FDA Law Blog) US: Docs at BIO: Steve Burrill’s state of the biotechnology industry report 2011 (Patent Docs) US: Counterfeiting: White House IP Czar Victoria Espinel on working with corporations (BIOtechNOW) US: Banning gene patents will promote innovation? [read post]
16 Mar 2017, 6:24 pm by Benjamin Wittes, Quinta Jurecic
A few hours later, the 9th Circuit Court of Appeals declined to review en banc the court’s earlier panel decision respecting the first version of the executive order. [read post]
9 Dec 2009, 3:59 pm
Watson Laboratories Inc. - Florida et al  (Patent Docs) Surfaxin (Lucinactant) – US: PTO rules on the availability of multiple interim patent extensions (FDA Law Blog) Taxotere (Docetaxel) – Canada: Federal Court refuses to grant Order of Prohibition against Hospira regarding Docetaxel product: Sanofi v Hospira (Pharmacapsules @ Gowlings) Vigamox (Moxifloxacin) – US: Teva appeals verdict finding ANDA to market generic Vigamox infringes patent: Alcon Inc. v. [read post]
12 Apr 2011, 10:07 pm by Marie Louise
General Open Access database of key HIV patents launched by medicines patent pool (IP Watch) Information challenges for product, process development and process design: a reality check (profitability through simplicity) ‘The price of innovation’: Report suggests that the cost of drug R&D is inflated (IP Osgoode) Preparing the world for influenza pandemic, industry role key, says WHO (IP Watch) Australia: Budget cuts threaten Australian medical research funding (Patentology)… [read post]
7 Jan 2015, 4:01 pm by INFORRM
  A legal challenge to S.1 of DRIPA by MPs David Davis and Tom Watson is under way. [read post]
22 Jul 2009, 6:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: India: Tarceva patent to be reviewed by Indian Supreme Court: Roche v Cipla (Spicy IP) (GenericsWeb) US follow-on biologics data exclusivity debate (Patent Docs) (Patent Docs) (IP Watchdog) (Managing Intellectual Property) (Patently BIOtech) (Patent Docs) (Patent Docs)   General Shift in IP top posts at WHO (Intellectual Property… [read post]